Why you'll see "RELA" in these tables: NF-κB is a protein pair — NFKB1 (p50) and RELA (p65) — that together switch on inflammation. It ranks #1 in 7 diseases and top 5 in 16. The problem: NFKB1 connects to so many organ systems (tox 83/100) that every drug aimed at NF-κB has failed or been pulled. But the two halves aren't identical. RELA carries 73% of the same disease connections as NFKB1 — the inflammatory ones you want to suppress — while missing the immune-safety wiring (IFN-γ, IL-10, MYD88, TGF-β1) that makes NFKB1 dangerous to touch. Its toxicity score is 5/100. A drug that targets p65 alone could suppress NF-κB-driven inflammation without the cross-organ damage. No such drug exists yet.